Showing results (1-10 of 106) with videos related to
Sort By:
Pageof 11
Current Opinion in Endocrinology, Diabetes, and Obesity|May 27, 2026
Normocalcemic primary hyperparathyroidism: an update on diagnostic and management challengesKrupa B Doshi, Manju ChandranOsteoporosis and Sarcopenia|February 19, 2019
Clinical aspects and management of osteoporosis and fragility fractures in patients with diabetesManju ChandranCurrent Osteoporosis Reports|September 13, 2013
Fracture Liaison Services in an open system: how was it done? what were the barriers and how were they overcome?Manju ChandranJournal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|July 17, 2017
Fracture Risk Assessment in Clinical Practice: Why Do It? What to Do It With?Manju ChandranArchives of Endocrinology and Metabolism|November 16, 2022
The why and how of sequential and combination therapy in osteoporosis. A review of the current evidenceManju ChandranVascular Health and Risk Management|June 20, 2008
Pramlintide, the synthetic analogue of amylin: physiology, pathophysiology, and effects on glycemic control, body weight, and selected biomarkers of vascular riskByron J Hoogwerf, Krupa B Doshi, Dima DiabFrontiers in Digital Health|July 25, 2024
Assessing fall risk in osteoporosis patients: a comparative study of age-matched fallers and nonfallersSeong Hyun Moon, Krupa B Doshi, Thurmon LockhartIndian Journal of Endocrinology and Metabolism|November 20, 2019
Secondary and Tertiary Hyperparathyroidism in Chronic Kidney Disease: An Endocrine and Renal PerspectiveManju Chandran, Jiunn WongArchives of Osteoporosis|December 11, 2012
Osteoporosis management and the utilization of FRAX®: a survey amongst health care professionals of the Asia-PacificDaniela Korthoewer, Manju Chandran, Pageof 11